Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2000-10-30
pubmed:abstractText
Immature CD4(+)CD8(+) thymocytes rearrange their T cell receptor (TCR)-alpha gene locus to generate clonotypic alpha/beta TCR, after which a few cells expressing selectable TCR are signaled to further differentiate into mature T cells. Because of requirements for self-tolerance, immature CD4(+)CD8(+) thymocytes are programmed to die in the thymus in response to a variety of stimuli that do not induce death of mature T cells. We now demonstrate that, in contrast to all previously described stimuli, immature CD4(+)CD8(+) thymocytes are selectively more resistant than mature T cells to apoptotic death induced by DNA intercalating agents. Importantly, we demonstrate that DNA intercalating agents induce double-stranded DNA breaks in both immature thymocytes and mature T cells, but immature thymocytes tolerate these DNA breaks, whereas mature T cells are signaled to die by an Atm-dependent but p53-independent death mechanism. Thus, our results indicate that absence of an Atm-dependent but p53-independent pathway allows immature thymocytes to survive double-stranded DNA breaks. It is likely that the unique ability of immature thymocytes to survive DNA-damaging intercalating agents reflects their tolerance of double-stranded DNA breaks that occur normally during antigen receptor gene rearrangements.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-10082576, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-10358774, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-10477747, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-10710310, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-10766245, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-1679836, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-1950799, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-2120773, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-2138780, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-2521375, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-2642507, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-4107107, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-6954467, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-7272306, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-7637809, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-7741032, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-7818898, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-7889408, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-7954799, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-8393478, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-8466628, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-8689683, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-8843193, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-8917548, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-8969240, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-9039786, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-9099796, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-9143695, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-9488723, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-9733515, http://linkedlifedata.com/resource/pubmed/commentcorrection/10993919-9915942
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
192
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
891-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10993919-Animals, pubmed-meshheading:10993919-Apoptosis, pubmed-meshheading:10993919-CD4-Positive T-Lymphocytes, pubmed-meshheading:10993919-CD8-Positive T-Lymphocytes, pubmed-meshheading:10993919-Cells, Cultured, pubmed-meshheading:10993919-Dactinomycin, pubmed-meshheading:10993919-Fas Ligand Protein, pubmed-meshheading:10993919-Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor, pubmed-meshheading:10993919-Genes, T-Cell Receptor alpha, pubmed-meshheading:10993919-Histones, pubmed-meshheading:10993919-Lymphocyte Activation, pubmed-meshheading:10993919-Membrane Glycoproteins, pubmed-meshheading:10993919-Mice, pubmed-meshheading:10993919-Mice, Inbred C3H, pubmed-meshheading:10993919-Mice, Inbred C57BL, pubmed-meshheading:10993919-Mice, Knockout, pubmed-meshheading:10993919-Mice, Transgenic, pubmed-meshheading:10993919-Phosphorylation, pubmed-meshheading:10993919-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:10993919-Spleen, pubmed-meshheading:10993919-T-Lymphocytes, pubmed-meshheading:10993919-Thymus Gland
pubmed:year
2000
pubmed:articleTitle
Immature thymocytes undergoing receptor rearrangements are resistant to an Atm-dependent death pathway activated in mature T cells by double-stranded DNA breaks.
pubmed:affiliation
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. bhandooa@exchange.nih.gov
pubmed:publicationType
Journal Article